Interferon Therapy Reduces Risk In Patients With HCV-Related Cirrhosis.
Publication: Hepatitis Weekly
Publication Date: 23-APR-01
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
by Sonia Nichols, staff medical writer - Patients with hepatitis-C-related liver cirrhosis can reduce their chances of developing liver cancer by taking long-term interferon (IFN) therapy.
A review of 694 chronic hepatitis C patients with liver cirrhosis has shown interferon treatments, when taking for a year or...
Read the full article for free courtesy of your local library.
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
